ArticleThe Journal of dermatological treatment2023

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.

L S van der Schoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.